Erturk, M. Et Al. 2014. Does intravenous or oral high-dose N-acetylcysteine in addition to saline prevent contrast-induced nephropathy assessed by cystatin C?. CORONARY ARTERY DISEASE , vol.25 , 111-117.

Erturk, M., Uslu, N., Gorgulu, S., Akbay, E., Kurtulus, G., Akturk, I. F. , ... Akgul, O.(2014). Does intravenous or oral high-dose N-acetylcysteine in addition to saline prevent contrast-induced nephropathy assessed by cystatin C?. CORONARY ARTERY DISEASE , vol.25, 111-117.

Erturk, Mehmet Et Al. "Does intravenous or oral high-dose N-acetylcysteine in addition to saline prevent contrast-induced nephropathy assessed by cystatin C?," CORONARY ARTERY DISEASE , vol.25, 111-117, 2014

Erturk, Mehmet Et Al. "Does intravenous or oral high-dose N-acetylcysteine in addition to saline prevent contrast-induced nephropathy assessed by cystatin C?." CORONARY ARTERY DISEASE , vol.25, pp.111-117, 2014

Erturk, M. Et Al. (2014) . "Does intravenous or oral high-dose N-acetylcysteine in addition to saline prevent contrast-induced nephropathy assessed by cystatin C?." CORONARY ARTERY DISEASE , vol.25, pp.111-117.

@article{article, author={Mehmet Erturk Et Al. }, title={Does intravenous or oral high-dose N-acetylcysteine in addition to saline prevent contrast-induced nephropathy assessed by cystatin C?}, journal={CORONARY ARTERY DISEASE}, year=2014, pages={111-117} }